Asia Spotlight: PhRMA Sees Good Japan Policy Progress, With Gaps
Executive Summary
PhRMA chairman Ian Read has laid out the U.S. industry association’s views on what’s good and not so good about the pharmaceutical operating environment in Japan. While there is now a much shorter wish list, the group still sees some room for improvement.